SJS Investment Consulting’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17
Closed -$304 – 3257
2026
Q2
$304 Buy
+17
New +$212 ﹤0.01% 2395

Other funds holding CLPT

SJS Investment Consulting's CLPT Position: Q3 2026 in Review

SJS Investment Consulting sold out of ClearPoint Neuro (CLPT) in Q3 2026, closing a stake of 17 shares — an estimated $304 sold.

SJS Investment Consulting first reported a position in CLPT in Q2 2026 and held it in 1 quarter. The position peaked at $304 in Q2 2026. 126 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • SJS Investment Consulting reported no remaining ClearPoint Neuro position as of Q3 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 17 ClearPoint Neuro shares in Q3 2026, an estimated $304.
  • SJS Investment Consulting first reported a position in ClearPoint Neuro in Q2 2026 and held it in 1 quarter.
  • SJS Investment Consulting's ClearPoint Neuro position peaked at $304 in Q2 2026.
  • 126 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.